Beta-sheet Aggregation
Beta-sheet Aggregation - Related Videos
01:21
Thioflavin-S Staining of Amyloid-Beta Aggregation in Cerebral Hypoperfused Mouse Brain Tissue
0 Views •
2025
MCCH is characterized by reduced blood flow to the brain. This limits oxygen and nutrient supply to the endothelial cell layer of cerebral blood vessels, damaging the cells.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
03:18
In Vitro Assessment of Aggregated Amyloid-β on Neuronal Growth Cone Collapse
0 Views •
2025
This video demonstrates an in vitro assessment of neuronal growth cone collapse by amyloid-β (Aβ) aggregates. Treating the neurons with Aβ aggregates causes cytoskeletal destabilization, leading to the collapse of growth cones at the tip of the axons. The treated cells are compared with control cells to assess the extent of growth cone collapse.
12:49
Measurement of Aggregate Cohesion by Tissue Surface Tensiometry
0 Views •
Cited by 10 •
2011
We describe a method of measuring binding energy, expressible as tissue surface tension, between cells within 3D tissue-like aggregates. Differences in tissue surface tension have been demonstrated to correlate with invasiveness of lung, muscle, and brain tumors, and are fundamental determinants of establishing spatial relationships between different cell types.
01:23
Balance Sheet
0 Views •
2024
A balance sheet is a key component of financial statement analysis. It provides a snapshot of a company's financial position at a given time by listing its assets, liabilities, and shareholders' equity. It includes both current and long-lived assets and current and long-term liabilities. Assets reflect what the company owns, such as cash, inventory, and real estate, whereas liabilities represent what the company owes, including debts like loans and accounts payable. Balance sheet analysis is...
FAQs
A nucleus provides an initial organized assembly that enables additional protein or peptide molecules to attach and align. Before this stage, aggregation-prone chains may remain dispersed or structurally unstable. After nucleation, assembly can proceed through fibril elongation and may produce larger aggregates, making nucleation a key point for understanding changes in aggregation kinetics.
Misfolding or partial unfolding can expose sequences that favor self-association. These exposed regions allow neighboring molecules to align and form backbone hydrogen bonds within repeating beta-sheet structures. The resulting interactions promote ordered assembly rather than isolated molecules, linking conformational instability to the formation of persistent protein or peptide deposits.
The organization of assembled molecules influences the form of the resulting deposit. Aligned chains can first produce fibrils, while continued association can generate larger aggregates. Studying this progression helps distinguish structural stages of beta-sheet aggregation and clarifies how changes in molecular organization may alter the effects of deposits in cells.
Researchers commonly focus on aggregation kinetics, structural transitions, and environmental triggers because these features describe when assembly begins, how rapidly it progresses, and how molecular organization changes. Examining them can reveal conditions associated with fibril formation or larger deposits and can support comparisons among protein or peptide systems.
In these disease-focused studies, aggregation is examined because amyloid-related deposits can disrupt cellular processes. The biological concern extends beyond the presence of an aggregate to how its formation and structural transitions affect cells. Characterizing these processes helps connect molecular assembly with disease mechanisms and supports investigation of potential therapeutic strategies.
Information about aggregation kinetics and structural transitions can help identify features associated with developing deposits, supporting biomarker research. The same knowledge provides a basis for evaluating how candidate interventions influence assembly. These applications connect mechanistic studies of protein aggregation with efforts to detect disease-related changes and screen therapeutic approaches.